MyLam
Lam Research Corporation Reports Financial Results for the Quarter Ended June 25, 2017
July 26, 2017

FREMONT, Calif.July 26, 2017 (GLOBE NEWSWIRE) -- Lam Research Corp. (Nasdaq:LRCX) today announced financial results for the quarter ended June 25, 2017 (the "June 2017 quarter").

Highlights for the June 2017 quarter were as follows:

  • Shipments of $2.54 billion and revenue of $2.34 billion.
  • GAAP gross margin of 45.6%, GAAP operating margin of 25.9%, and GAAP diluted EPS of $2.82.
  • Non-GAAP gross margin of 46.5%, non-GAAP operating margin of 27.7%, and non-GAAP diluted EPS of $3.11.

 

Key Financial Data for the Quarters Ended June 25, 2017 and March 26, 2017 
(in thousands, except per-share data, percentages, and basis points)
 
U.S. GAAP
    June 2017   March 2017   Change Q/Q
Shipments   $ 2,542,664     $ 2,412,656     + 5 %
Revenue   $ 2,344,907     $ 2,153,995     + 9 %
Gross margin as percentage of revenue   45.6 %   45.1 %   + 50 bps  
Operating margin as percentage of revenue   25.9 %   25.0 %   + 90 bps  
Diluted EPS   $ 2.82     $ 3.10     - 9 %
 
Non-GAAP
    June 2017   March 2017   Change Q/Q
Shipments   $ 2,542,664     $ 2,412,656     + 5 %
Revenue   $ 2,344,907     $ 2,153,995     + 9 %
Gross margin as percentage of revenue   46.5 %   46.1 %   + 40 bps  
Operating margin as percentage of revenue   27.7 %   26.9 %   + 80 bps  
Diluted EPS   $ 3.11     $ 2.80     + 11 %
                       
 

U.S. GAAP Financial Results

For the June 2017 quarter, revenue was $2,345 million, gross margin was $1,069 million, or 45.6% of revenue, operating expenses were $461 million, operating margin was 25.9% of revenue, and net income was $526 million, or $2.82 per diluted share on a GAAP basis. This compares to revenue of $2,154 million, gross margin of $971 million, or 45.1% of revenue, operating expenses of $433 million, operating margin of 25.0% of revenue, and net income of $575 million, or $3.10 per diluted share, for the quarter ended March 26, 2017 (the "March 2017 quarter").

Non-GAAP Financial Results

For the June 2017 quarter, non-GAAP gross margin was $1,090 million or 46.5% of revenue, non-GAAP operating expenses were $440 million, non-GAAP operating margin was 27.7% of revenue, and non-GAAP net income was $566 million, or $3.11 per diluted share. This compares to non-GAAP gross margin of $993 million or 46.1% of revenue, non-GAAP operating expenses of $414 million, non-GAAP operating margin of 26.9% of revenue, and non-GAAP net income of $508 million, or $2.80 per diluted share for the March 2017 quarter.

"Lam delivered another record quarter for shipments, revenue and non-GAAP operating income in June, capping a record fiscal 2017 highlighted by over eight and a half billion dollars in shipments and nearly ten dollars in non-GAAP diluted earnings per share," said Martin Anstice, Lam Research's President and Chief Executive Officer. "Demand trends in our key end markets have improved, and we are on track once again to outperform overall industry growth in calendar 2017. Longer-term, our increased strategic relevance enabling a new generation of technology innovations, combined with broad competitive strength, deliver a compelling value creation opportunity for Lam."

Balance Sheet and Cash Flow Results

Cash and cash equivalents, short-term investments, and restricted cash and investments balances increased to $6.3 billion at the end of the June 2017 quarter compared to $6.1 billion at the end of the March 2017 quarter. This increase was primarily the result of approximately $729 million of cash generated in operating activities, partially offset by $526 million of share repurchases, including net share settlement on employee stock-based compensation.

Deferred revenue at the end of the June 2017 quarter increased to $966 million as compared to $842 million at the end of the March 2017 quarter. Deferred profit at the end of the June 2017 quarter increased to $608 million as compared to $527 million at the end of the March 2017 quarter. Lam's deferred revenue balance does not include shipments to Japanese customers, to whom title does not transfer until customer acceptance. Shipments to Japanese customers are classified as inventory at cost until the time of acceptance. The estimated future revenue from shipments to Japanese customers was approximately $397 million as of June 25, 2017 and $260 million as of March 26, 2017.

Geographic Distribution

The geographic distribution of shipments and revenue during the June 2017 quarter is shown in the following table:

Region Shipments   Revenue
Korea 36 %   38 %
Japan 21 %   17 %
China 16 %   16 %
Taiwan 14 %   16 %
United States 8 %   9 %
Europe 3 %   3 %
Southeast Asia 2 %   1 %
 

Outlook

For the September 2017 quarter, Lam is providing the following guidance:

  U.S. GAAP   Reconciling
Items
  Non-GAAP
Shipments $2.35 Billion +/- $100 Million     $2.35 Billion +/- $100 Million
Revenue $2.45 Billion +/- $100 Million     $2.45 Billion +/- $100 Million
Gross margin   45.6 % +/-   1 %   $ 21   Million     46.5 % +/-   1 %
Operating margin   26.5 % +/-   1 %   $ 37   Million     28.0 % +/-   1 %
Net income per diluted share $ 2.98   +/- $ 0.12     $ 37   Million   $ 3.25   +/- $ 0.12  
Diluted share count 187 Million   4   Million   183 million
               
 

The information provided above is only an estimate of what the Company believes is realizable as of the date of this release, and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, balance sheet valuation adjustments, financing arrangements, other investments, or other significant transactions that may be completed after the date of this release. U.S. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:

  • Gross margin - amortization related to intangible assets acquired in the Novellus transaction, $21 million.
  • Operating margin - amortization related to intangible assets acquired in the Novellus transaction, $37 million.
  • Earnings per share - amortization related to intangible assets acquired in the Novellus transaction, $37 million;  amortization of note discounts, $6 million; and associated tax benefit for non-GAAP items ($6) million; totaling $37 million.
  • Diluted share count - impact of a note hedge issued contemporaneously with the convertible notes due 2018, 4 million shares.

Use of Non-GAAP Financial Results

In addition to U.S. GAAP results, this press release also contains non-GAAP financial results. The Company's non-GAAP results for both the June 2017 and March 2017 quarters exclude amortization related to intangible assets acquired in the Novellus transaction, costs associated with business process reengineering, the amortization of notes discounts, tax benefit of non-GAAP items, and income tax benefit on the conclusion of tax matters related to a prior business combination.

Management uses non-GAAP gross margin, operating expense, operating income, operating margin, net income, and net income per diluted share to evaluate the Company's operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors' ability to view the Company's results from management's perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company's website at http://investor.lamresearch.com.

Caution Regarding Forward-Looking Statements

Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to; the estimated future revenue from shipments to Japanese customers; our revenue, industry, performance and general outlooks, and their drivers; our future strategic relevance to customers; the potential for value creation; technology demand trends; the legal and business factors that may affect our future tax rate; and our guidance for shipments, revenue, gross margin, operating margin, net income or earnings per diluted share, and diluted share count. Some factors that may affect these forward-looking statements include: business conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; and the actions of our customers and competitors may be inconsistent with our expectations, as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our annual report on Form 10-K for the fiscal year ended June 26, 2016 and quarterly reports on Form 10-Q for the fiscal quarters ended September 25, 2016December 25, 2016 and March 26, 2017. These uncertainties and changes could materially affect the forward looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this release.

About Lam Research

Lam Research Corp. is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. As a trusted, collaborative partner to the world's leading semiconductor companies, we combine superior systems engineering capability, technology leadership, and unwavering commitment to customer success to accelerate innovation through enhanced device performance. In fact, today, nearly every advanced chip is built with Lam technology. Lam Research (Nasdaq:LRCX) is a FORTUNE 500® company headquartered in Fremont, Calif., with operations around the globe. Learn more at www.lamresearch.com. (LRCX-F)

Consolidated Financial Tables Follow.

LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data and percentages)
 
  Three Months Ended   Twelve Months Ended
  June 25,
2017
  March 26,
2017
  June 26,
2016
  June 25,
2017
  June 26,
2016
  (unaudited)   (unaudited)   (unaudited)   (unaudited)   (1)  
Revenue $ 2,344,907     $ 2,153,995     $ 1,546,261     $ 8,013,620     $ 5,885,893  
Cost of goods sold 1,275,946     1,182,591     847,477     4,410,261     3,266,971  
Gross margin 1,068,961     971,404     698,784     3,603,359     2,618,922  
Gross margin as a percent of revenue 45.6 %   45.1 %   45.2 %   45.0 %   44.5 %
Research and development 285,712     265,986     237,255     1,033,742     913,712  
Selling, general and administrative 175,310     167,000     152,288     667,485     630,954  
Total operating expenses 461,022     432,986     389,543     1,701,227     1,544,666  
Operating income 607,939     538,418     309,241     1,902,132     1,074,256  
Operating income as a percent of revenue 25.9 %   25.0 %   20.0 %   23.7 %   18.3 %
Other expense, net (4,444 )   (7,838 )   (27,249 )   (90,459 )   (114,139 )
Income before income taxes 603,495     530,580     281,992     1,811,673     960,117  
Income tax (expense) benefit (77,071 )   44,133     (23,053 )   (113,910 )   (46,068 )
Net income $ 526,424     $ 574,713     $ 258,939     $ 1,697,763     $ 914,049  
Net income per share:                  
Basic $ 3.25     $ 3.52     $ 1.62     $ 10.47     $ 5.75  
Diluted $ 2.82     $ 3.10     $ 1.46     $ 9.24     $ 5.22  
Number of shares used in per share calculations:                  
Basic 162,213     163,408     159,862     162,222     158,919  
Diluted 186,427     185,094     177,649     183,770     175,159  
Cash dividend declared per common share $ 0.45     $ 0.45     $ 0.30     $ 1.65     $ 1.20  
 
(1) Derived from audited financial statements.
 

 

LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
 
  June 25,
2017
  March 26,
2017
  June 26,
2016
 
  (unaudited)   (unaudited)   (1)    
ASSETS            
Cash and cash equivalents $ 2,377,534     $ 2,128,570     $ 5,039,322    
Investments 3,663,628     3,755,036     1,788,612    
Accounts receivable, net 1,673,398     1,636,090     1,262,145    
Inventories 1,232,916     1,133,196     971,911    
Other current assets 195,022     223,056     151,160   (2 )
Total current assets 9,142,498     8,875,948     9,213,150    
Property and equipment, net 685,595     675,707     639,608    
Restricted cash and investments 256,205     256,157     250,421    
Goodwill and intangible assets 1,796,668     1,835,150     1,951,197    
Other assets 241,799     232,224     209,939   (2 )
Total assets $ 12,122,765     $ 11,875,186     $ 12,264,315    
LIABILITIES AND STOCKHOLDERS' EQUITY            
Current portion of convertible notes and capital leases $ 908,439     $ 905,288     $ 947,733   (2 )
Other current liabilities 2,041,676     1,851,451     1,470,308    
Total current liabilities 2,950,115     2,756,739     2,418,041    
Long-term debt and capital leases 1,784,974     1,777,297     3,378,129   (2 )
Income taxes payable 120,178     137,173     231,514    
Other long-term liabilities 280,186     282,615     134,562    
Total liabilities 5,135,453     4,953,824     6,162,246    
Temporary equity, convertible notes 169,861     175,108     207,552    
Stockholders' equity (3) 6,817,451     6,746,254     5,894,517    
Total liabilities and stockholders' equity $ 12,122,765     $ 11,875,186     $ 12,264,315    
             
(1) Derived from audited financial statements.            
(2) Adjusted for effects of retrospective implementation of ASU 2015-3, regarding the simplification of the presentation of bond issuance costs, which requires that bond issuance costs related to a recognized liability be presented on the balance sheet as a direct reduction from the carrying amount of that debt liability, consistent with debt discounts.  
(3) Common shares issued and outstanding were 161,723 as of June 25, 2017, 163,969 as of March 26, 2017 and 160,201 as of June 26, 2016.  
 

           

LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
 
  Three Months Ended   Twelve Months Ended
  June 25,
2017
  March 26,
2017
  June 26,
2016
  June 25,
2017
  June 26,
2016
  (unaudited)   (unaudited)   (unaudited)   (unaudited)   (1)  
CASH FLOWS FROM OPERATING ACTIVITIES:                  
Net income $ 526,424     $ 574,713     $ 258,939     $ 1,697,763     $ 914,049  
Adjustments to reconcile net income to net cash provided by operating activities:                  
Depreciation and amortization 79,036     76,242     74,976     306,905     291,028  
Deferred income taxes 35,069     27,619     (46,708 )   104,936     (49,003 )
Equity-based compensation expense 43,802     35,323     39,288     149,975     142,348  
(Gain) Loss on early extinguishment of debt (73 )           36,252      
Income tax benefit (expense) on equity-based compensation plans 38,747         (8,048 )   38,747     (1,023 )
Excess tax (benefit) expense on equity-based compensation plans (38,635 )       9,035     (38,635 )   1,020  
Amortization of note discounts and issuance costs 6,114     6,136     14,584     25,282     70,522  
Gain on sale of assets, net (163 )       (15,223 )   (163 )   (15,223 )
Other, net 8,275     (4,738 )   17,929     19,052     48,788  
Changes in operating assets and liabilities 30,676     (292,607 )   79,052     (310,832 )   (52,229 )
Net cash provided by operating activities 729,272     422,688     423,824     2,029,282     1,350,277  
CASH FLOWS FROM INVESTING ACTIVITIES:                  
Capital expenditures and intangible assets (34,811 )   (44,116 )   (51,726 )   (157,419 )   (175,330 )
Net sale (purchase) of available-for-sale securities 93,858     (418,566 )   605,891     (1,883,886 )   798,828  
Proceeds from sale of assets 290         79,730     1,291     79,730  
Transfers of restricted cash and investments (48 )   (982 )   (112,381 )   (5,784 )   (112,381 )
Other, net (187 )   (3,586 )       (12,815 )   1,636  
Net cash provided by (used for) investing activities 59,102     (467,250 )   521,514     (2,058,613 )   592,483  
CASH FLOWS FROM FINANCING ACTIVITIES:                  
Principal payments on long-term debt and capital lease obligations (2,445 )   (69,227 )   (450,624 )   (1,688,313 )   (451,497 )
Proceeds from issuance of long-term debt, net of issuance costs         2,374,220         2,338,144  
Excess tax benefit (expense) on equity-based compensation plans 38,635         (9,035 )   38,635     (1,020 )
Treasury stock purchases (525,778 )   (216,373 )   (27,114 )   (811,672 )   (158,389 )
Dividends paid (73,709 )   (73,337 )   (47,308 )   (243,495 )   (190,402 )
Re-issuance of treasury stock related to employee stock purchase plan 23,120     17,223     20,360     59,663     55,992  
Proceeds from issuance of common stock 369     7,964     1,547     12,913     3,405  
Other, net (1 )   (70 )   (159 )   (125 )   (488 )
Net cash (used for) provided by financing activities (539,809 )   (333,820 )   1,861,887     (2,632,394 )   1,595,745  
Effect of exchange rate changes on cash and cash equivalents 399     2,992     76     (63 )   (722 )
Net increase (decrease) in cash and cash equivalents 248,964     (375,390 )   2,807,301     (2,661,788 )   3,537,783  
Cash and cash equivalents at beginning of period 2,128,570     2,503,960     2,232,021     5,039,322     1,501,539  
Cash and cash equivalents at end of period $ 2,377,534     $ 2,128,570     $ 5,039,322     $ 2,377,534     $ 5,039,322  
                   
(1) Derived from audited financial statements.                  
 

               

 

Non-GAAP Financial Summary
(in thousands, except percentages and per share data)
(unaudited)
 
  Three Months Ended
  June 25,
2017
  March 26,
2017
Revenue $ 2,344,907     $ 2,153,995  
Gross margin $ 1,090,211     $ 992,654  
Gross margin as percentage of revenue 46.5 %   46.1 %
Operating expenses $ 440,126     $ 414,229  
Operating income $ 650,085     $ 578,425  
Operating margin as a percentage of revenue 27.7 %   26.9 %
Net income $ 565,518     $ 507,751  
Net income per diluted share $ 3.11     $ 2.80  
Shares used in per share calculation - diluted 182,093     181,539  
 

 

Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income and U.S. GAAP number of dilutive shares to Non-GAAP number of dilutive shares
(in thousands, except per share data)
(unaudited)
 
  Three Months Ended
  June 25,
2017
  March 26,
2017
U.S. GAAP net income $ 526,424     $ 574,713  
Pre-tax non-GAAP items:      
Amortization related to intangible assets acquired in Novellus transaction - cost of goods sold 21,250     21,250  
Amortization related to intangible assets acquired in Novellus transaction -selling, general and administrative 16,083     16,083  
Cost associated with business process reengineering- selling, general and administrative 4,813     2,674  
Amortization of note discounts - other expense, net 5,631     5,654  
Net income tax benefit on non-GAAP items (5,697 )   (6,418 )
Income tax benefit on conclusion of certain tax matters (2,986 )   (106,205 )
Non-GAAP net income $ 565,518     $ 507,751  
Non-GAAP net income per diluted share $ 3.11     $ 2.80  
U.S. GAAP number of shares used for per diluted share calculation 186,427     185,094  
Effect of convertible note hedge (4,334 )   (3,555 )
Non-GAAP number of shares used for per diluted share calculation 182,093     181,539  
 

 

Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income and U.S. GAAP number of dilutive shares to Non-GAAP number of dilutive shares
(in thousands, except per share data)
(unaudited)
 
  Twelve Months Ended
  June 25,
 2017
  June 26,
 2016
U.S. GAAP net income $ 1,697,763     $ 914,049  
Pre-tax non-GAAP items:      
Amortization related to intangible assets acquired in Novellus transaction - cost of goods sold 85,000     85,000  
Product rationalization - cost of goods sold 6,127      
Novellus acquisition-related inventory fair value impact - cost of goods sold     777  
Restructuring charges - cost of goods sold     371  
Restructuring charges - research and development     4,355  
Product rationalization - research and development 1,650      
Cost associated with campus consolidation - research and development 3,556     7,763  
KLA-Tencor acquisition-related costs - selling, general and administrative 9,972     50,985  
Gain on sale of assets, net associated exit costs -  selling, general and administrative     (15,223 )
Amortization related to intangible assets acquired in Novellus transaction -selling, general and administrative 64,332     64,333  
Restructuring charges - selling, general and administrative     4,997  
Costs associated with business process reengineering - selling, general and administrative 7,487      
Litigation settlement - selling, general and administrative 4,000      
Amortization of note discounts - other expense, net 22,869     35,205  
Costs related to early termination of KLA-Tencor acquisition funding - other expense, net 34,518      
Amortization of bridge loan issuance costs and other related fees - other expense, net     33,843  
KLA-Tencor pre-acquisition funding interest expense, net - other expense, net 20,391     3,821  
Net income tax benefit on non-GAAP items (47,941 )   (49,859 )
Income tax benefit on conclusion of certain tax matters (109,191 )   (3,017 )
Change to income tax benefit due to a court ruling     (22,812 )
Income tax benefit related to tax extenders, primarily the research and development credit     (13,603 )
Non-GAAP net income $ 1,800,533     $ 1,100,985  
Non-GAAP net income per diluted share $ 9.98     $ 6.37  
U.S. GAAP number of shares used for per diluted share calculation 183,770     175,159  
Effect of convertible note hedge (3,302 )   (2,398 )
Non-GAAP number of shares used for per diluted share calculation 180,468     172,761  
 

 

Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income
(in thousands, except percentages)
(unaudited)
 
  Three Months Ended
  June 25,
2017
  March 26,
2017
  December 25,
2016
  September 25,
2016
U.S. GAAP gross margin $ 1,068,961     $ 971,404     $ 846,797     $ 716,197  
Pre-tax non-GAAP items:              
Amortization related to intangible assets acquired in Novellus transaction 21,250     21,250     21,250     21,250  
Product rationalization         6,127      
Non-GAAP gross margin $ 1,090,211     $ 992,654     $ 874,174     $ 737,447  
U.S. GAAP gross margin as a percentage of revenue 45.6 %   45.1 %   45.0 %   43.9 %
Non-GAAP gross margin as a percentage of revenue 46.5 %   46.1 %   46.4 %   45.2 %
U.S. GAAP operating expenses $ 461,022     $ 432,986     $ 406,969     $ 400,250  
Pre-tax non-GAAP items:              
Amortization related to intangible assets acquired in Novellus transaction (16,083 )   (16,083 )   (16,083 )   (16,083 )
Costs associated with business process reengineering (4,813 )   (2,674 )        
KLA-Tencor acquisition-related costs             (9,972 )
Product rationalization         (1,650 )    
Cost associated with campus consolidation         (995 )   (2,561 )
Litigation settlement         (4,000 )    
Non-GAAP operating expenses $ 440,126     $ 414,229     $ 384,241     $ 371,634  
Non-GAAP operating income $ 650,085     $ 578,425     $ 489,933     $ 365,813  
GAAP operating margin as percent of revenue 25.9 %   25.0 %   23.4 %   19.4 %
Non-GAAP operating margin as a percent of revenue 27.7 %   26.9 %   26.0 %   22.4 %
 

 

Lam Research Corporation Contacts:

Satya Kumar, Investor Relations, phone: 510-572-1615, e-mail: investor.relations@lamresearch.com

Primary Logo

 

Source:  Lam Research

 

News Provided by Acquire Media

circle-arrow2circle-arrow2facebookgooglehandshake2health2linkedinmenupdfplant2searchtwitteryoutube